then I think if your endoscopist friend is a convert he needs to be put on the podium by OSL to provide some expert but favourable commentary to the market!
The test now would seem to be the outcomes for the 10 who got resected. We need to see this data, not just survival but also disease free duration . And coming back to your first point would be good to see how many of those resected actually had BR disease at outset.
OSL Top Pick for FY21, page-12
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $56.76M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.5¢ | 1.3¢ | $76.04K | 5.442M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 450000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 9713598 | 7 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |